Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
NOV Inc. price target raised to $27 from $26 at Cowen » 07:38
02/08/23
02/08
07:38
02/08/23
07:38
NOV

NOV Inc.

$23.25 /

-0.13 (-0.56%)

Cowen analyst Marc…

Cowen analyst Marc Bianchi raised the firm's price target on NOV Inc. to $27 from $26 and keeps an Outperform rating on the shares. The analyst said they reported a solid 4Q but 1Q guide was essentially inline with consensus.

ShowHide Related Items >><<
NOV NOV Inc.
$23.25 /

-0.13 (-0.56%)

NOV NOV Inc.
$23.25 /

-0.13 (-0.56%)

02/08/23 Susquehanna
NOV Inc. price target raised to $29 from $26 at Susquehanna
01/19/23 Benchmark
NOV Inc. initiated with a Buy at Benchmark
01/04/23 Morgan Stanley
NOV Inc. upgraded to Overweight from Equal Weight at Morgan Stanley
12/09/22 Raymond James
NOV Inc. initiated with an Outperform at Raymond James
NOV NOV Inc.
$23.25 /

-0.13 (-0.56%)

NOV NOV Inc.
$23.25 /

-0.13 (-0.56%)

NOV NOV Inc.
$23.25 /

-0.13 (-0.56%)

Recommendations
NOV Inc. price target raised to $29 from $26 at Susquehanna » 07:26
02/08/23
02/08
07:26
02/08/23
07:26
NOV

NOV Inc.

$23.25 /

-0.13 (-0.56%)

Susquehanna analyst…

Susquehanna analyst Charles Minervino raised the firm's price target on NOV Inc. to $29 from $26 and keeps a Positive rating on the shares. The analyst said we believe NOV is entering a key part of its cycle that should include strong revenue growth, margin expansion, and order activity. It also appears supply bottlenecks are loosening, which should bode well for delivering on backlog and margins.

ShowHide Related Items >><<
NOV NOV Inc.
$23.25 /

-0.13 (-0.56%)

NOV NOV Inc.
$23.25 /

-0.13 (-0.56%)

01/19/23 Benchmark
NOV Inc. initiated with a Buy at Benchmark
01/04/23 Morgan Stanley
NOV Inc. upgraded to Overweight from Equal Weight at Morgan Stanley
12/09/22 Raymond James
NOV Inc. initiated with an Outperform at Raymond James
11/07/22 Wells Fargo
Wells Fargo upgrades NOV Inc. to Equal Weight, raises price target to $25
NOV NOV Inc.
$23.25 /

-0.13 (-0.56%)

NOV NOV Inc.
$23.25 /

-0.13 (-0.56%)

NOV NOV Inc.
$23.25 /

-0.13 (-0.56%)

Hot Stocks
NOV Inc. sees using cash to fund 'meaningful growth' in business » 11:31
02/07/23
02/07
11:31
02/07/23
11:31
NOV

NOV Inc.

$23.87 /

+0.49 (+2.10%)

NOV said on its Q4…

NOV said on its Q4 earnings conference call that it is committed to returning excess capital to shareholders, wh ether it's through increasing the dividend or a share repurchase program. At the same time, NOV sees the anticipated near-term uses of cash to fund "meaningful growth" in its businesses, along with an M&A environment "that is looking a bit more constructive," means it is not ready to increase return of capital to shareholders at this time.

ShowHide Related Items >><<
NOV NOV Inc.
$23.87 /

+0.49 (+2.10%)

01/19/23 Benchmark
NOV Inc. initiated with a Buy at Benchmark
01/04/23 Morgan Stanley
NOV Inc. upgraded to Overweight from Equal Weight at Morgan Stanley
12/09/22 Raymond James
NOV Inc. initiated with an Outperform at Raymond James
11/07/22 Wells Fargo
Wells Fargo upgrades NOV Inc. to Equal Weight, raises price target to $25
NOV NOV Inc.
$23.87 /

+0.49 (+2.10%)

NOV NOV Inc.
$23.87 /

+0.49 (+2.10%)

NOV NOV Inc.
$23.87 /

+0.49 (+2.10%)

On The Fly
Fly Intel: After-Hours Movers » 18:15
02/06/23
02/06
18:15
02/06/23
18:15
SKY

Skyline Champion

$60.06 /

-2.025 (-3.26%)

, INTA

Intapp

$28.35 /

-0.58 (-2.00%)

, KMT

Kennametal

$29.56 /

-0.655 (-2.17%)

, SAVE

Spirit Airlines

$19.60 /

-0.135 (-0.68%)

, NOV

NOV Inc.

$23.38 /

+0.11 (+0.47%)

, SWKS

Skyworks

$109.30 /

-3.19 (-2.84%)

, GNW

Genworth

$5.67 /

-0.065 (-1.13%)

, LMT

Lockheed Martin

$469.21 /

+10.065 (+2.19%)

, CHGG

Chegg

$21.04 /

-0.305 (-1.43%)

, AOSL

Alpha & Omega

$36.08 /

-1.1 (-2.96%)

, ZI

ZoomInfo

$28.74 /

-0.34 (-1.17%)

, PETS

PetMed Express

$20.47 /

-1.6 (-7.25%)

, PINS

Pinterest

$27.93 /

+0.455 (+1.66%)

, LEG

Leggett & Platt

$35.98 /

-1.245 (-3.34%)

, RMBS

Rambus

$43.15 /

-0.45 (-1.03%)

, FN

Fabrinet

$132.10 /

-0.98 (-0.74%)

, BBBY

Bed Bath & Beyond

$5.85 /

+2.8 (+91.80%)

, BLNK

Blink Charging

$13.83 /

-0.21 (-1.50%)

Check out this evening's…

ShowHide Related Items >><<
ZI ZoomInfo
$28.74 /

-0.34 (-1.17%)

SWKS Skyworks
$109.30 /

-3.19 (-2.84%)

SAVE Spirit Airlines
$19.60 /

-0.135 (-0.68%)

RMBS Rambus
$43.15 /

-0.45 (-1.03%)

PINS Pinterest
$27.93 /

+0.455 (+1.66%)

PETS PetMed Express
$20.47 /

-1.6 (-7.25%)

LMT Lockheed Martin
$469.21 /

+10.065 (+2.19%)

LEG Leggett & Platt
$35.98 /

-1.245 (-3.34%)

INTA Intapp
$28.35 /

-0.58 (-2.00%)

GNW Genworth
$5.67 /

-0.065 (-1.13%)

FN Fabrinet
$132.10 /

-0.98 (-0.74%)

CHGG Chegg
$21.04 /

-0.305 (-1.43%)

BLNK Blink Charging
$13.83 /

-0.21 (-1.50%)

BBBY Bed Bath & Beyond
$5.85 /

+2.8 (+91.80%)

AOSL Alpha & Omega
$36.08 /

-1.1 (-2.96%)

SKY Skyline Champion
$60.06 /

-2.025 (-3.26%)

12/30/22 Wedbush
Wedbush favors four homebuilding stocks heading into 2023
12/14/22 Barclays
Skyline Champion downgraded to Equal Weight from Overweight at Barclays
11/03/22 Craig-Hallum
Skyline Champion price target lowered to $65 from $75 at Craig-Hallum
11/03/22 RBC Capital
Skyline Champion cut to Sector Perform at RBC Capital on sharp decline in orders
INTA Intapp
$28.35 /

-0.58 (-2.00%)

11/08/22 Credit Suisse
Intapp price target raised to $27 from $22 at Credit Suisse
11/08/22 Piper Sandler
Intapp price target raised to $26 from $19 at Piper Sandler
09/08/22 Truist
Intapp price target lowered to $28 from $45 at Truist
09/08/22 Raymond James
Intapp price target lowered to $20 from $26 at Raymond James
KMT Kennametal
$29.56 /

-0.655 (-2.17%)

10/03/22 Barclays
Kennametal price target lowered to $24 from $25 at Barclays
08/03/22 Barclays
Kennametal price target lowered to $25 from $26 at Barclays
07/20/22 Loop Capital
Kennametal price target lowered to $22 from $29 at Loop Capital
07/15/22 Jefferies
Kennametal price target lowered to $35 from $45 at Jefferies
SAVE Spirit Airlines
$19.60 /

-0.135 (-0.68%)

12/20/22 Deutsche Bank
Spirit Airlines downgraded on regulatory process at Deutsche Bank
12/20/22 Deutsche Bank
Spirit Airlines downgraded to Hold from Buy at Deutsche Bank
11/01/22 Citi
Spirit Airlines price target raised to $23 from $22 at Citi
09/30/22 Citi
Spirit Airlines reinstated with a Neutral at Citi (yesterday)
NOV NOV Inc.
$23.38 /

+0.11 (+0.47%)

01/19/23 Benchmark
NOV Inc. initiated with a Buy at Benchmark
01/04/23 Morgan Stanley
NOV Inc. upgraded to Overweight from Equal Weight at Morgan Stanley
12/09/22 Raymond James
NOV Inc. initiated with an Outperform at Raymond James
11/07/22 Wells Fargo
Wells Fargo upgrades NOV Inc. to Equal Weight, raises price target to $25
SWKS Skyworks
$109.30 /

-3.19 (-2.84%)

01/23/23 Barclays
Skyworks upgraded to Overweight from Equal Weight at Barclays
01/11/23 KeyBanc
KeyBanc says iPhone survey shows supply partial recovery, some shortages remain
11/30/22 KGI Securities
Skyworks upgraded to Outperform from Neutral at KGI Securities
11/15/22 Credit Suisse
Skyworks assumed with an Outperform at Credit Suisse
GNW Genworth
$5.67 /

-0.065 (-1.13%)

LMT Lockheed Martin
$469.21 /

+10.065 (+2.19%)

02/06/23 Credit Suisse
Lockheed Martin double upgraded to Outperform at Credit Suisse
02/06/23 Credit Suisse
Lockheed Martin upgraded to Outperform from Underperform at Credit Suisse
01/30/23 DZ Bank
Lockheed Martin upgraded to Buy from Hold at DZ Bank
01/25/23 Credit Suisse
Lockheed Martin price target raised to $408 from $384 at Credit Suisse
CHGG Chegg
$21.04 /

-0.305 (-1.43%)

01/23/23 Jefferies
Fears around ChatGPT impact on Chegg 'more bark than bite,' says Jefferies
01/19/23 KeyBanc
Chegg upgraded to Overweight on margin potential at KeyBanc
01/19/23 KeyBanc
Chegg upgraded to Overweight from Sector Weight at KeyBanc
01/18/23 BMO Capital
Chegg traffic declining as ChatGPT may pose subs headwinds, says BMO Capital
AOSL Alpha & Omega
$36.08 /

-1.1 (-2.96%)

10/04/22 B. Riley
Alpha & Omega price target lowered to $38 from $45 at B. Riley
08/11/22 B. Riley
Alpha & Omega price target raised to $45 from $42 at B. Riley
08/11/22 Benchmark
Alpha & Omega price target lowered to $60 from $70 at Benchmark
06/15/22 B. Riley
B. Riley downgrades eight semi stocks on 'demand destruction risk'
ZI ZoomInfo
$28.74 /

-0.34 (-1.17%)

02/01/23 Raymond James
ZoomInfo price target lowered to $33 from $41 at Raymond James
01/20/23 UBS
ZoomInfo price target lowered to $34 from $37 at UBS
01/10/23 Truist
Truist cuts ZoomInfo to Hold, sees headwind from Q3 persisting
01/10/23 Barclays
ZoomInfo price target lowered to $36 from $46 at Barclays
PETS PetMed Express
$20.47 /

-1.6 (-7.25%)

09/21/22 Jefferies
PetMed Express transferred with a Hold at Jefferies
PINS Pinterest
$27.93 /

+0.455 (+1.66%)

01/30/23 DA Davidson
DA Davidson neutral on Pinterest ahead of earnings
01/20/23 MKM Partners
MKM Partners cuts Pinterest to Neutral, sees balanced risk-reward
01/20/23 MKM Partners
Pinterest downgraded to Neutral from Buy at MKM Partners
01/19/23 JPMorgan
JPMorgan calls out Meta as top pick ahead of earnings from online ads group
LEG Leggett & Platt
$35.98 /

-1.245 (-3.34%)

12/12/22 Piper Sandler
Leggett & Platt downgraded to Underweight from Neutral at Piper Sandler
10/11/22 Truist
Leggett & Platt price target lowered to $35 from $41 at Truist
10/11/22 Piper Sandler
Leggett & Platt price target lowered to $31 from $37 at Piper Sandler
06/14/22 Piper Sandler
Leggett & Platt price target lowered to $36 from $40 at Piper Sandler
RMBS Rambus
$43.15 /

-0.45 (-1.03%)

02/03/23 Susquehanna
Rambus price target raised to $60 from $36 at Susquehanna
01/30/23 Deutsche Bank
Rambus price target raised to $45 from $34 at Deutsche Bank
01/18/23 Wells Fargo
Rambus price target raised to $50 from $42 at Wells Fargo
01/09/23 Wells Fargo
Rambus price target raised to $42 from $35 at Wells Fargo
FN Fabrinet
$132.10 /

-0.98 (-0.74%)

12/20/22 JPMorgan
Fabrinet upgraded to Overweight from Neutral at JPMorgan
11/08/22 B. Riley
Fabrinet price target raised to $110 from $102 at B. Riley
11/08/22 Needham
Fabrinet price target raised to $140 from $135 at Needham
10/06/22 Northland
Fabrinet price target raised to $132.50 from $125 at Northland
BBBY Bed Bath & Beyond
$5.85 /

+2.8 (+91.80%)

01/11/23 Wedbush
Bed Bath & Beyond price target lowered to $1 from $5 at Wedbush
01/11/23 Baird
Bed Bath & Beyond price target lowered to $1.00 from $2.00 at Baird
01/05/23 Wells Fargo
Wells halves Bed Bath & Beyond target to $1, says bankruptcy may be 'imminent'
11/28/22 Wedbush
Black Friday winners Include Best Buy, losers include Pets, says Wedbush
BLNK Blink Charging
$13.83 /

-0.21 (-1.50%)

11/07/22 B. Riley
Blink Charging price target lowered to $14 from $15 at B. Riley
08/16/22 Stifel
Blink Charging price target raised to $23 from $19 at Stifel
06/22/22 Stifel
Blink Charging price target lowered to $19 from $30 at Stifel
06/17/22 B. Riley
B. Riley sees challenges for Blink Charging, starts with Neutral
ZI ZoomInfo
$28.74 /

-0.34 (-1.17%)

SWKS Skyworks
$109.30 /

-3.19 (-2.84%)

SKY Skyline Champion
$60.06 /

-2.025 (-3.26%)

SAVE Spirit Airlines
$19.60 /

-0.135 (-0.68%)

RMBS Rambus
$43.15 /

-0.45 (-1.03%)

PINS Pinterest
$27.93 /

+0.455 (+1.66%)

PETS PetMed Express
$20.47 /

-1.6 (-7.25%)

NOV NOV Inc.
$23.38 /

+0.11 (+0.47%)

LMT Lockheed Martin
$469.21 /

+10.065 (+2.19%)

LEG Leggett & Platt
$35.98 /

-1.245 (-3.34%)

KMT Kennametal
$29.56 /

-0.655 (-2.17%)

INTA Intapp
$28.35 /

-0.58 (-2.00%)

GNW Genworth
$5.67 /

-0.065 (-1.13%)

FN Fabrinet
$132.10 /

-0.98 (-0.74%)

CHGG Chegg
$21.04 /

-0.305 (-1.43%)

BLNK Blink Charging
$13.83 /

-0.21 (-1.50%)

BBBY Bed Bath & Beyond
$5.85 /

+2.8 (+91.80%)

AOSL Alpha & Omega
$36.08 /

-1.1 (-2.96%)

  • 07
    Feb
SAVE Spirit Airlines
$19.60 /

-0.135 (-0.68%)

PINS Pinterest
$27.93 /

+0.455 (+1.66%)

LMT Lockheed Martin
$469.21 /

+10.065 (+2.19%)

BBBY Bed Bath & Beyond
$5.85 /

+2.8 (+91.80%)

ZI ZoomInfo
$28.74 /

-0.34 (-1.17%)

SWKS Skyworks
$109.30 /

-3.19 (-2.84%)

SAVE Spirit Airlines
$19.60 /

-0.135 (-0.68%)

PINS Pinterest
$27.93 /

+0.455 (+1.66%)

NOV NOV Inc.
$23.38 /

+0.11 (+0.47%)

LMT Lockheed Martin
$469.21 /

+10.065 (+2.19%)

LEG Leggett & Platt
$35.98 /

-1.245 (-3.34%)

INTA Intapp
$28.35 /

-0.58 (-2.00%)

FN Fabrinet
$132.10 /

-0.98 (-0.74%)

CHGG Chegg
$21.04 /

-0.305 (-1.43%)

BBBY Bed Bath & Beyond
$5.85 /

+2.8 (+91.80%)

AOSL Alpha & Omega
$36.08 /

-1.1 (-2.96%)

ZI ZoomInfo
$28.74 /

-0.34 (-1.17%)

SWKS Skyworks
$109.30 /

-3.19 (-2.84%)

SAVE Spirit Airlines
$19.60 /

-0.135 (-0.68%)

RMBS Rambus
$43.15 /

-0.45 (-1.03%)

PINS Pinterest
$27.93 /

+0.455 (+1.66%)

PETS PetMed Express
$20.47 /

-1.6 (-7.25%)

NOV NOV Inc.
$23.38 /

+0.11 (+0.47%)

LMT Lockheed Martin
$469.21 /

+10.065 (+2.19%)

LEG Leggett & Platt
$35.98 /

-1.245 (-3.34%)

GNW Genworth
$5.67 /

-0.065 (-1.13%)

CHGG Chegg
$21.04 /

-0.305 (-1.43%)

BLNK Blink Charging
$13.83 /

-0.21 (-1.50%)

BBBY Bed Bath & Beyond
$5.85 /

+2.8 (+91.80%)

Earnings
NOV Inc. reports Q4 EPS 26c, consensus 24c » 17:02
02/06/23
02/06
17:02
02/06/23
17:02
NOV

NOV Inc.

$23.38 /

+0.11 (+0.47%)

Reports Q4 revenue…

Reports Q4 revenue $2.07B, consensus $1.95B. "Our fourth quarter results reflect a strong finish to a year that saw rising demand for NOV's products and services, gradually normalizing global supply chains, and improving execution by our organization," stated Clay Williams, CEO. "For the past two years, our short-cycle businesses within North America have driven our post-pandemic recovery. As we completed 2022, we began to see international and offshore markets inflect and accelerate, a trend we expect to drive improving orders for our longer-cycle businesses over the next few years and beyond. While recent declines in North American natural gas prices and persistent global recession risks may pose near-term headwinds to oilfield activity, we believe that the world simply must rebuild and fortify its petroleum supply capability soon and a sustained oil and gas up-cycle is required to increase energy security across the globe. Years of chronic underinvestment and a pandemic lockdown that severely stunted capacity make this up-cycle all the more urgent and daunting. NOV is up to the challenge. We stand ready to equip the industry with the tools necessary to do the job efficiently, economically, safely, and with minimal environmental impact."

ShowHide Related Items >><<
NOV NOV Inc.
$23.38 /

+0.11 (+0.47%)

01/19/23 Benchmark
NOV Inc. initiated with a Buy at Benchmark
01/04/23 Morgan Stanley
NOV Inc. upgraded to Overweight from Equal Weight at Morgan Stanley
12/09/22 Raymond James
NOV Inc. initiated with an Outperform at Raymond James
11/07/22 Wells Fargo
Wells Fargo upgrades NOV Inc. to Equal Weight, raises price target to $25
NOV NOV Inc.
$23.38 /

+0.11 (+0.47%)

NOV NOV Inc.
$23.38 /

+0.11 (+0.47%)

NOV NOV Inc.
$23.38 /

+0.11 (+0.47%)

Options
National Oilwell options imply 6.2% move in share price post-earnings » 15:04
02/06/23
02/06
15:04
02/06/23
15:04
NOV

NOV Inc.

$23.26 /

-0.005 (-0.02%)

Pre-earnings options…

Pre-earnings options volume in National Oilwell is 2.8x normal with calls leading puts 6:1. Implied volatility suggests the market is anticipating a move near 6.2%, or $1.44, after results are released. Median move over the past eight quarters is 3.8%.

ShowHide Related Items >><<
NOV NOV Inc.
$23.26 /

-0.005 (-0.02%)

01/19/23 Benchmark
NOV Inc. initiated with a Buy at Benchmark
01/04/23 Morgan Stanley
NOV Inc. upgraded to Overweight from Equal Weight at Morgan Stanley
12/09/22 Raymond James
NOV Inc. initiated with an Outperform at Raymond James
11/07/22 Wells Fargo
Wells Fargo upgrades NOV Inc. to Equal Weight, raises price target to $25
NOV NOV Inc.
$23.26 /

-0.005 (-0.02%)

NOV NOV Inc.
$23.26 /

-0.005 (-0.02%)

On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 10:14
01/19/23
01/19
10:14
01/19/23
10:14
PTEN

Patterson-UTI

$16.10 /

-0.01 (-0.06%)

, IBM

IBM

$141.12 /

+0.73 (+0.52%)

, OLED

Universal Display

$127.44 /

-0.06 (-0.05%)

, PM

Philip Morris

$101.60 /

+2.36 (+2.38%)

, CHGG

Chegg

$20.49 /

+0.12 (+0.59%)

, CVAC

CureVac

$9.87 /

+0.385 (+4.06%)

, RBLX

Roblox

$33.32 /

-2.44 (-6.82%)

, SCHW

Charles Schwab

$77.18 /

-4.205 (-5.17%)

, CTSH

Cognizant

$60.94 /

-0.04 (-0.07%)

, DXC

DXC Technology

$28.35 /

-0.615 (-2.12%)

, TEVA

Teva

$10.36 /

-0.485 (-4.47%)

, TEL

TE Connectivity

$121.17 /

-2.06 (-1.67%)

, SHYF

Shyft Group

$30.25 /

+0.82 (+2.79%)

, GEHC

GE HealthCare

$62.75 /

+0.74 (+1.19%)

, HAL

Halliburton

$40.42 /

-0.13 (-0.32%)

, WHD

Cactus

$51.81 /

-0.96 (-1.82%)

, NE

Noble Corp.

$40.02 /

+0.295 (+0.74%)

, VAL

Valaris

$73.00 /

+0.94 (+1.30%)

, FTI

TechnipFMC

$12.55 /

+0.13 (+1.05%)

, RIG

Transocean

$5.87 /

+0.15 (+2.62%)

, OII

Oceaneering

$18.39 /

+0.045 (+0.25%)

, NOV

NOV Inc.

$22.58 /

-0.225 (-0.99%)

, BKR

Baker Hughes

$30.54 /

-0.13 (-0.42%)

, SLB

SLB

$56.74 /

-0.38 (-0.67%)

, HP

Helmerich & Payne

$47.17 /

-0.355 (-0.75%)

, PUMP

ProPetro Holding

$9.42 /

-0.055 (-0.58%)

, ALPN

Alpine Immune Sciences

$8.09 /

+0.12 (+1.51%)

, KPTI

Karyopharm

$3.26 /

+0.19 (+6.20%)

Institutional investors…

ShowHide Related Items >><<
WHD Cactus
$51.81 /

-0.96 (-1.82%)

VAL Valaris
$73.00 /

+0.94 (+1.30%)

TEVA Teva
$10.36 /

-0.485 (-4.47%)

TEL TE Connectivity
$121.17 /

-2.06 (-1.67%)

SLB SLB
$56.74 /

-0.38 (-0.67%)

SHYF Shyft Group
$30.25 /

+0.82 (+2.79%)

SCHW Charles Schwab
$77.18 /

-4.205 (-5.17%)

RIG Transocean
$5.87 /

+0.15 (+2.62%)

RBLX Roblox
$33.32 /

-2.44 (-6.82%)

PUMP ProPetro Holding
$9.42 /

-0.055 (-0.58%)

PTEN Patterson-UTI
$16.10 /

-0.01 (-0.06%)

PM Philip Morris
$101.60 /

+2.36 (+2.38%)

OLED Universal Display
$127.44 /

-0.06 (-0.05%)

OII Oceaneering
$18.39 /

+0.045 (+0.25%)

NE Noble Corp.
$40.02 /

+0.295 (+0.74%)

KPTI Karyopharm
$3.26 /

+0.19 (+6.20%)

IBM IBM
$141.12 /

+0.73 (+0.52%)

HP Helmerich & Payne
$47.17 /

-0.355 (-0.75%)

HAL Halliburton
$40.42 /

-0.13 (-0.32%)

GEHC GE HealthCare
$62.75 /

+0.74 (+1.19%)

FTI TechnipFMC
$12.55 /

+0.13 (+1.05%)

DXC DXC Technology
$28.35 /

-0.615 (-2.12%)

CVAC CureVac
$9.87 /

+0.385 (+4.06%)

CTSH Cognizant
$60.94 /

-0.04 (-0.07%)

CHGG Chegg
$20.49 /

+0.12 (+0.59%)

BKR Baker Hughes
$30.54 /

-0.13 (-0.42%)

ALPN Alpine Immune Sciences
$8.09 /

+0.12 (+1.51%)

PTEN Patterson-UTI
$16.10 /

-0.01 (-0.06%)

01/19/23 Benchmark
Patterson-UTI initiated with a Hold at Benchmark
01/17/23 Citi
Patterson-UTI downgraded to Neutral from Buy at Citi
12/09/22 Raymond James
Patterson-UTI initiated with a Strong Buy at Raymond James
10/07/22 Piper Sandler
Patterson-UTI assumed with an Overweight at Piper Sandler
IBM IBM
$141.12 /

+0.73 (+0.52%)

01/19/23 MoffettNathanson
IBM upgraded to Market Perform from Underperform at MoffettNathanson
01/18/23 Morgan Stanley
IBM downgraded to Equal Weight at Morgan Stanley amid shift away from defense
01/18/23 Morgan Stanley
IBM downgraded to Equal Weight from Overweight at Morgan Stanley
01/17/23 Evercore ISI
IBM price target raised to $150 from $135 at Evercore ISI
OLED Universal Display
$127.44 /

-0.06 (-0.05%)

01/19/23 Susquehanna
Universal Display upgraded to Neutral from Negative at Susquehanna
11/21/22 Citi
Universal Display price target lowered to $135 from $150 at Citi
11/04/22 Oppenheimer
Universal Display price target lowered to $135 from $150 at Oppenheimer
11/04/22 TD Cowen
Universal Display price target lowered to $130 from $145 at Cowen
PM Philip Morris
$101.60 /

+2.36 (+2.38%)

01/19/23 Jefferies
Philip Morris upgraded at Jefferies as tobacco sentiment may 'finally' improve
01/19/23 Jefferies
Philip Morris upgraded to Buy from Hold at Jefferies
12/13/22 Citi
Philip Morris resumed with a Neutral at Citi
11/15/22 Argus
Philip Morris upgraded to Buy from Hold at Argus
CHGG Chegg
$20.49 /

+0.12 (+0.59%)

01/19/23 KeyBanc
Chegg upgraded to Overweight on margin potential at KeyBanc
01/19/23 KeyBanc
Chegg upgraded to Overweight from Sector Weight at KeyBanc
01/18/23 BMO Capital
Chegg traffic declining as ChatGPT may pose subs headwinds, says BMO Capital
01/18/23 Needham
Needham downgrades Chegg to Hold as long-term initiatives limit growth upside
CVAC CureVac
$9.87 /

+0.385 (+4.06%)

01/19/23 UBS
UBS upgrades CureVac after 'major milestone and clearing event'
01/19/23 UBS
CureVac upgraded to Buy from Neutral at UBS
01/09/23 Jefferies
CureVac upgraded to Buy at Jefferies after mRNA platform validation
01/09/23 Jefferies
CureVac upgraded to Buy from Hold at Jefferies
RBLX Roblox
$33.32 /

-2.44 (-6.82%)

01/19/23 Morgan Stanley
Roblox downgraded to Underweight from Equal Weight at Morgan Stanley
01/19/23 Morgan Stanley
Roblox downgraded to Underweight from Equal Weight at Morgan Stanley
01/18/23 Needham
Roblox price target raised to $42 from $39 at Needham
01/18/23 BTIG
Roblox December outperformance due to core monetization, gift cards, says BTIG
SCHW Charles Schwab
$77.18 /

-4.205 (-5.17%)

01/19/23 BofA
Charles Schwab double downgraded to Underperform at BofA
01/19/23 BofA
Charles Schwab downgraded to Underperform from Buy at BofA
01/17/23 William Blair
Charles Schwab initiated with an Outperform at William Blair
01/04/23 Goldman Sachs
Charles Schwab upgraded to Buy from Neutral at Goldman Sachs
CTSH Cognizant
$60.94 /

-0.04 (-0.07%)

01/19/23 MoffettNathanson
Cognizant downgraded to Underperform from Market Perform at MoffettNathanson
01/15/23 UBS
Cognizant price target raised to $68 from $62 at UBS
01/13/23 BMO Capital
Cognizant price target raised to $71 from $65 at BMO Capital
01/09/23 BofA
Cognizant downgraded to Underperform from Neutral at BofA
DXC DXC Technology
$28.35 /

-0.615 (-2.12%)

01/19/23 MoffettNathanson
DXC Technology downgraded to Underperform at MoffettNathanson
12/15/22 JPMorgan
DXC Technology upgraded to Neutral from Underweight at JPMorgan
10/14/22 JPMorgan
DXC Technology price target lowered to $31 from $33 at JPMorgan
10/05/22 Citi
Citi says $38 target on DXC does not include buyout premium
TEVA Teva
$10.36 /

-0.485 (-4.47%)

01/19/23 Jefferies
Teva downgraded to Hold from Buy at Jefferies
01/06/23 Northland
Alvotech named a top pick for 2023 at Northland
11/23/22 Piper Sandler
Teva price target lowered to $7 from $8 at Piper Sandler
11/14/22 JPMorgan
Teva downgraded to Underweight from Neutral at JPMorgan
TEL TE Connectivity
$121.17 /

-2.06 (-1.67%)

01/19/23 Evercore ISI
TE Connectivity downgraded to In Line at Evercore ISI on auto market headwinds
01/19/23 Evercore ISI
TE Connectivity downgraded to In Line from Outperform at Evercore ISI
12/20/22 JPMorgan
TE Connectivity price target lowered to $130 from $135 at JPMorgan
12/12/22 Credit Suisse
TE Connectivity initiated with a Neutral at Credit Suisse
SHYF Shyft Group
$30.25 /

+0.82 (+2.79%)

01/19/23 BTIG
Shyft Group initiated with a Buy at BTIG
07/13/22 DA Davidson
Shyft Group upgraded to Buy at DA Davidson on improving commercial van sales
07/13/22 DA Davidson
Shyft Group upgraded to Buy from Neutral at DA Davidson
04/06/22 DA Davidson
DA Davidson cuts Shyft Group to Neutral, citing caution on near-term earnings
GEHC GE HealthCare
$62.75 /

+0.74 (+1.19%)

01/19/23 Redburn
GE HealthCare initiated with a Buy at Redburn
01/09/23 BofA
General Electric price target lowered to $85 from $105 at BofA
01/04/23 Edward Jones
GE HealthCare initiated with a Hold at Edward Jones
12/06/22 Oppenheimer
General Electric upgraded to Outperform from Perform at Oppenheimer
HAL Halliburton
$40.42 /

-0.13 (-0.32%)

01/19/23 Benchmark
Halliburton initiated with a Buy at Benchmark
01/12/23 Wolfe Research
Halliburton upgraded to Outperform from Underperform at Wolfe Research
12/09/22 Raymond James
Halliburton initiated with a Strong Buy at Raymond James
11/29/22 Citi
Halliburton should take equity stake in Chart Industries, says Citi
WHD Cactus
$51.81 /

-0.96 (-1.82%)

01/19/23 Benchmark
Cactus initiated with a Buy at Benchmark
11/13/22 Citi
Cactus price target raised to $58 from $47 at Citi
11/08/22 BofA
Cactus price target raised to $59 from $45 at BofA
10/07/22 Piper Sandler
Cactus assumed with a Neutral at Piper Sandler
NE Noble Corp.
$40.02 /

+0.295 (+0.74%)

01/19/23 Benchmark
Noble Corp. initiated with a Buy at Benchmark
07/06/22 DNB Markets
Noble Corp. price target raised to $49 from $43 at DNB Markets
06/01/22 BTIG
Noble Corp. upgraded to Buy from Neutral at BTIG
02/08/22 Evercore ISI
Noble Corp. resumed with an Outperform at Evercore ISI
VAL Valaris
$73.00 /

+0.94 (+1.30%)

01/19/23 Benchmark
Valaris initiated with a Buy at Benchmark
01/03/23 BTIG
Helix Energy named Top Pick for first half of 2023 at BTIG
06/01/22 BTIG
Valaris price target raised to $80 from $60 at BTIG
FTI TechnipFMC
$12.55 /

+0.13 (+1.05%)

01/19/23 Benchmark
TechnipFMC initiated with a Buy at Benchmark
01/03/23 BTIG
TechnipFMC named Top Pick for first half of 2023 at BTIG
11/18/22 Piper Sandler
TechnipFMC price target raised to $17 from $13 at Piper Sandler
10/25/22 HSBC
TechnipFMC upgraded to Buy from Hold at HSBC
RIG Transocean
$5.87 /

+0.15 (+2.62%)

01/19/23 Benchmark
Transocean initiated with a Buy at Benchmark
11/18/22 Piper Sandler
Transocean price target raised to $5 from $4 at Piper Sandler
10/17/22 Susquehanna
Transocean price target lowered to $3.30 from $4.20 at Susquehanna
10/07/22 Piper Sandler
Transocean assumed with a Neutral at Piper Sandler
OII Oceaneering
$18.39 /

+0.045 (+0.25%)

01/19/23 Benchmark
Oceaneering initiated with a Buy at Benchmark
10/19/22 Citi
Oceaneering price target lowered to $16 from $20 at Citi
10/07/22 Piper Sandler
Oceaneering assumed with a Neutral at Piper Sandler
10/06/22 Barclays
Barclays downgrades Oceaneering on lack of 'earnings torque'
NOV NOV Inc.
$22.58 /

-0.225 (-0.99%)

01/19/23 Benchmark
NOV Inc. initiated with a Buy at Benchmark
01/04/23 Morgan Stanley
NOV Inc. upgraded to Overweight from Equal Weight at Morgan Stanley
12/09/22 Raymond James
NOV Inc. initiated with an Outperform at Raymond James
11/07/22 Wells Fargo
Wells Fargo upgrades NOV Inc. to Equal Weight, raises price target to $25
BKR Baker Hughes
$30.54 /

-0.13 (-0.42%)

01/19/23 Benchmark
Baker Hughes initiated with a Buy at Benchmark
10/26/22 Wells Fargo
Wells Fargo downgrades 'show me' stock Baker Hughes to neutral
10/26/22 Wells Fargo
Baker Hughes downgraded to Equal Weight from Overweight at Wells Fargo
SLB SLB
$56.74 /

-0.38 (-0.67%)

01/19/23 Benchmark
SLB initiated with a Buy at Benchmark
01/12/23 Wolfe Research
SLB downgraded to Peer Perform from Outperform at Wolfe Research
12/09/22 Raymond James
SLB initiated with an Outperform at Raymond James
11/18/22 Piper Sandler
SLB price target raised to $64 from $60 at Piper Sandler
HP Helmerich & Payne
$47.17 /

-0.355 (-0.75%)

01/19/23 Benchmark
Helmerich & Payne initiated with a Hold at Benchmark
01/09/23 BofA
Helmerich & Payne upgraded to Buy from Neutral at BofA
11/18/22 RBC Capital
Helmerich & Payne price target raised to $68 from $63 at RBC Capital
11/18/22 Susquehanna
Helmerich & Payne price target raised to $65 from $62 at Susquehanna
PUMP ProPetro Holding
$9.42 /

-0.055 (-0.58%)

01/19/23 Benchmark
ProPetro Holding initiated with a Hold at Benchmark
01/17/23 Citi
ProPetro Holding downgraded to Neutral from Buy at Citi
01/10/23 Barclays
ProPetro Holding upgraded to Overweight from Equal Weight at Barclays
10/07/22 Piper Sandler
ProPetro Holding assumed with an Overweight at Piper Sandler
ALPN Alpine Immune Sciences
$8.09 /

+0.12 (+1.51%)

01/19/23 Morgan Stanley
Alpine Immune Sciences initiated with an Overweight at Morgan Stanley
11/21/22 SVB Securities
Alpine Immune Sciences initiated with an Outperform at SVB Securities
10/24/22 Oppenheimer
Alpine Immune price target lowered to $14 from $17 at Oppenheimer
10/24/22 H.C. Wainwright
Alpine Immune Sciences price target lowered to $8 from $21 at H.C. Wainwright
KPTI Karyopharm
$3.26 /

+0.19 (+6.20%)

01/19/23 Piper Sandler
Karyopharm initiated with an Overweight at Piper Sandler
01/10/23 H.C. Wainwright
Karyopharm price target lowered to $16 from $18 at H.C. Wainwright
01/02/23 Barclays
Barclays views GSK acquisition interest as positive for oncology stocks
11/04/22 RBC Capital
Karyopharm upgraded to Outperform from Sector Perform at RBC Capital
WHD Cactus
$51.81 /

-0.96 (-1.82%)

VAL Valaris
$73.00 /

+0.94 (+1.30%)

TEVA Teva
$10.36 /

-0.485 (-4.47%)

TEL TE Connectivity
$121.17 /

-2.06 (-1.67%)

SLB SLB
$56.74 /

-0.38 (-0.67%)

SHYF Shyft Group
$30.25 /

+0.82 (+2.79%)

SCHW Charles Schwab
$77.18 /

-4.205 (-5.17%)

RIG Transocean
$5.87 /

+0.15 (+2.62%)

RBLX Roblox
$33.32 /

-2.44 (-6.82%)

PUMP ProPetro Holding
$9.42 /

-0.055 (-0.58%)

PTEN Patterson-UTI
$16.10 /

-0.01 (-0.06%)

PM Philip Morris
$101.60 /

+2.36 (+2.38%)

OLED Universal Display
$127.44 /

-0.06 (-0.05%)

OII Oceaneering
$18.39 /

+0.045 (+0.25%)

NOV NOV Inc.
$22.58 /

-0.225 (-0.99%)

NE Noble Corp.
$40.02 /

+0.295 (+0.74%)

KPTI Karyopharm
$3.26 /

+0.19 (+6.20%)

IBM IBM
$141.12 /

+0.73 (+0.52%)

HP Helmerich & Payne
$47.17 /

-0.355 (-0.75%)

HAL Halliburton
$40.42 /

-0.13 (-0.32%)

GEHC GE HealthCare
$62.75 /

+0.74 (+1.19%)

FTI TechnipFMC
$12.55 /

+0.13 (+1.05%)

DXC DXC Technology
$28.35 /

-0.615 (-2.12%)

CVAC CureVac
$9.87 /

+0.385 (+4.06%)

CTSH Cognizant
$60.94 /

-0.04 (-0.07%)

CHGG Chegg
$20.49 /

+0.12 (+0.59%)

BKR Baker Hughes
$30.54 /

-0.13 (-0.42%)

ALPN Alpine Immune Sciences
$8.09 /

+0.12 (+1.51%)

  • 11
    Jan
  • 21
    Sep
  • 02
    Aug
TEVA Teva
$10.36 /

-0.485 (-4.47%)

SLB SLB
$56.74 /

-0.38 (-0.67%)

SCHW Charles Schwab
$77.18 /

-4.205 (-5.17%)

RBLX Roblox
$33.32 /

-2.44 (-6.82%)

PM Philip Morris
$101.60 /

+2.36 (+2.38%)

IBM IBM
$141.12 /

+0.73 (+0.52%)

DXC DXC Technology
$28.35 /

-0.615 (-2.12%)

BKR Baker Hughes
$30.54 /

-0.13 (-0.42%)

WHD Cactus
$51.81 /

-0.96 (-1.82%)

TEVA Teva
$10.36 /

-0.485 (-4.47%)

TEL TE Connectivity
$121.17 /

-2.06 (-1.67%)

SLB SLB
$56.74 /

-0.38 (-0.67%)

SCHW Charles Schwab
$77.18 /

-4.205 (-5.17%)

RIG Transocean
$5.87 /

+0.15 (+2.62%)

RBLX Roblox
$33.32 /

-2.44 (-6.82%)

PTEN Patterson-UTI
$16.10 /

-0.01 (-0.06%)

PM Philip Morris
$101.60 /

+2.36 (+2.38%)

OLED Universal Display
$127.44 /

-0.06 (-0.05%)

KPTI Karyopharm
$3.26 /

+0.19 (+6.20%)

IBM IBM
$141.12 /

+0.73 (+0.52%)

HP Helmerich & Payne
$47.17 /

-0.355 (-0.75%)

HAL Halliburton
$40.42 /

-0.13 (-0.32%)

GEHC GE HealthCare
$62.75 /

+0.74 (+1.19%)

FTI TechnipFMC
$12.55 /

+0.13 (+1.05%)

DXC DXC Technology
$28.35 /

-0.615 (-2.12%)

CVAC CureVac
$9.87 /

+0.385 (+4.06%)

CTSH Cognizant
$60.94 /

-0.04 (-0.07%)

CHGG Chegg
$20.49 /

+0.12 (+0.59%)

BKR Baker Hughes
$30.54 /

-0.13 (-0.42%)

TEVA Teva
$10.36 /

-0.485 (-4.47%)

SLB SLB
$56.74 /

-0.38 (-0.67%)

SCHW Charles Schwab
$77.18 /

-4.205 (-5.17%)

RIG Transocean
$5.87 /

+0.15 (+2.62%)

RBLX Roblox
$33.32 /

-2.44 (-6.82%)

PTEN Patterson-UTI
$16.10 /

-0.01 (-0.06%)

PM Philip Morris
$101.60 /

+2.36 (+2.38%)

NE Noble Corp.
$40.02 /

+0.295 (+0.74%)

IBM IBM
$141.12 /

+0.73 (+0.52%)

HP Helmerich & Payne
$47.17 /

-0.355 (-0.75%)

HAL Halliburton
$40.42 /

-0.13 (-0.32%)

GEHC GE HealthCare
$62.75 /

+0.74 (+1.19%)

FTI TechnipFMC
$12.55 /

+0.13 (+1.05%)

DXC DXC Technology
$28.35 /

-0.615 (-2.12%)

CTSH Cognizant
$60.94 /

-0.04 (-0.07%)

BKR Baker Hughes
$30.54 /

-0.13 (-0.42%)

Initiation
NOV Inc. initiated with a Buy at Benchmark » 07:05
01/19/23
01/19
07:05
01/19/23
07:05
NOV

NOV Inc.

$22.81 /

-0.785 (-3.33%)

Benchmark analyst Kurt…

Benchmark analyst Kurt Hallead initiated coverage of NOV Inc. with a Buy rating and $28 price target. NOV is in a strong position to benefit from the need for energy sector to upgrade, enhance and rebuild existing equipment as well as re-stock depleted inventories to meet future demand for oil, gas and renewables, Hallead tells investors in a research note. Everything NOV manufactures is essential to securing current and future energy supplies, the analyst contends.

ShowHide Related Items >><<
NOV NOV Inc.
$22.81 /

-0.785 (-3.33%)

01/04/23 Morgan Stanley
NOV Inc. upgraded to Overweight from Equal Weight at Morgan Stanley
12/09/22 Raymond James
NOV Inc. initiated with an Outperform at Raymond James
11/07/22 Wells Fargo
Wells Fargo upgrades NOV Inc. to Equal Weight, raises price target to $25
11/07/22 Wells Fargo
NOV Inc. upgraded to Equal Weight from Underweight at Wells Fargo
NOV NOV Inc.
$22.81 /

-0.785 (-3.33%)

Upgrade
NOV Inc. upgraded to Overweight from Equal Weight at Morgan Stanley » 04:58
01/04/23
01/04
04:58
01/04/23
04:58
NOV

NOV Inc.

$19.86 /

-1.035 (-4.95%)

Morgan Stanley analyst…

Morgan Stanley analyst Connor Lynagh upgraded NOV Inc. to Overweight from Equal Weight with a price target of $24, up from $21. NOV is the largest global supplier of oilfield services equipment, and its exposure is "thematically aligned with where we see meaningful growth," Lynagh tells investors in a research note. NOV is a critical equipment supplier to offshore drilling markets, which are reaching a "meaningful inflection after years in the doldrums," says the analyst. Lynagh sees meaningful free cash flow revisions upside for the next year.

ShowHide Related Items >><<
NOV NOV Inc.
$19.86 /

-1.035 (-4.95%)

12/09/22 Raymond James
NOV Inc. initiated with an Outperform at Raymond James
11/07/22 Wells Fargo
Wells Fargo upgrades NOV Inc. to Equal Weight, raises price target to $25
11/07/22 Wells Fargo
NOV Inc. upgraded to Equal Weight from Underweight at Wells Fargo
11/01/22 Barclays
NOV Inc. price target raised to $25 from $22 at Barclays
NOV NOV Inc.
$19.86 /

-1.035 (-4.95%)

Over a quarter ago
Initiation
NOV Inc. initiated with an Outperform at Raymond James » 09:09
12/09/22
12/09
09:09
12/09/22
09:09
NOV

NOV Inc.

$20.31 /

+0.02 (+0.10%)

Raymond James analyst…

Raymond James analyst James Rollyson initiated coverage of NOV Inc. with an Outperform rating and $30 price target as part of relaunching coverage of the oilfield services sector. A sustained period of underinvestment, coupled with rising energy transition pressures, set up the current oil supply situation, for "which there is no short term fix," Rollyson tells investors. Capital discipline and asset rationalization across the oilfield service sector has put a lid on how quickly the industry could ramp back up, which "portends a more bullish set up for a longer cycle with sustained free cash flow generation" and an extended period of strong margins, the analyst contends.

ShowHide Related Items >><<
NOV NOV Inc.
$20.31 /

+0.02 (+0.10%)

11/07/22 Wells Fargo
Wells Fargo upgrades NOV Inc. to Equal Weight, raises price target to $25
11/07/22 Wells Fargo
NOV Inc. upgraded to Equal Weight from Underweight at Wells Fargo
11/01/22 Barclays
NOV Inc. price target raised to $25 from $22 at Barclays
10/31/22 Susquehanna
NOV Inc. price target lowered to $25 from $27 at Susquehanna
NOV NOV Inc.
$20.31 /

+0.02 (+0.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.